|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"hsu sj"
Showing items 1-10 of 31 (4 Page(s) Totally)
1 2 3 4 > >>
View [10|25|50] records per page
| 國家衛生研究院 |
2025-04-04 |
Cytotoxicity-guided isolation of elatostemanosides I-VI from Elatostema tenuicaudatum W. T. Wang and their cytotoxic activities
|
Huynh, QDT;Phan, TTT;Liu, TW;Duong, TLT;Hsu, SJ;Kuo, CC;Chu, MH;Wang, YH;Nguyen, TV;Shen, YA;Fan, YJ;Nguyen, DK;Vo, TH;Lee, CK |
| 國家衛生研究院 |
2023-12-31 |
Systemic treatments in pancreatic cancer: Taiwan pancreas society recommendation
|
Su, YY;Chiang, NJ;Chiu, TJ;Huang, CJ;Hsu, SJ;Lin, HC;Yang, SH;Yang, Y;Chou, WC;Chen, YY;Bai, LY;Li, CP;Chen, JS |
| 中山醫學大學 |
2021 |
EIGHT-YEAR ENTECAVIR THERAPY CONTINUOUSLY REDUCES LIVER ADVERSE EVENTS IN CHRONIC HEPATITIS B PATIENTS WITH CIRRHOSIS
|
Su, TH; Hu, TH; Chuang, WL; Su, WW; Lin, CC; Peng, CY; Wang, CC; Hsu, YC; Huang, YW; Tseng, KC; Lin, CL; Yang, SS; Suk, FM; Hsu, SJ; Chen, TM; Bair, MJ; Lin, CK; Hsieh, TY; Wang, HY; Tseng, TC; Kao, JH |
| 中山醫學大學 |
2021 |
Improvement of Bacterial Vaginosis by Oral Lactobacillus Supplement: A Randomized, Double-Blinded Trial
|
Lin, TC; Hsu, IL; Tsai, WH; Chu, YC; Kuan, LC; Huang, MS; Yeh, WL; Chen, YH; Hsu, SJ; Chang, WW |
| 中山醫學大學 |
2020 |
IMPACT OF SOFOSBUVIR-BASED VERSUS NON-SOFOSBUVIR-BASED DIRECT-ACTING ANTIVIRALS ON RENAL FUNCTION IN CHRONIC HEPATITIS C PATIENTS WITH IMPAIRED RENAL FUNCTION- A LARGE COHORT STUDY FROM THE NATIONWIDE REAL-WORLD HCV REGISTRY PROGRAM (TACR)
|
Yu, ML; Chen, CY; Yi, C; Cheng, PN; Tseng, KC; Lo, CC; Hung, CH; Lin, CY; Chen, CH; Peng, CY; Bair, MJ; Hsieh, TY; Lee, PL; Yang, CC; Lin, CL; Mo, LR; Su, WW; Tsai, WL; Chang, CC; Lin, CC; Hsu, SJ; Liu, CH; Huang, YH; Hu, CT; Liu, CJ; Kao, JH; Lee, MH; Chien, RN; Dai, CY; Tsai, PC |
| 中山醫學大學 |
2020 |
Risk of hepatocellular carcinoma development after hepatitis C virus eradicated by direct-acting antivirals: Fact or fiction?
|
Hsu, SJ; Yang, SS; Kao, JH |
| 國家衛生研究院 |
2019-04-01 |
A novel, potent, and orally bioavailable thiazole HCV NS5A inhibitor for the treatment of hepatitis C virus
|
Yeh, TK;Kang, IJ;Hsu, TA;Lee, YC;Lee, CC;Hsu, SJ;Tian, YW;Yang, HY;Chen, CT;Chao, YS;Yueh, A;Chern, JH |
| 臺大學術典藏 |
2018-09-10T06:14:05Z |
Noninvasive diagnosis of hepatic fibrosis in patients with chronic hepatitis C by splenic Doppler impedance index.
|
Hsu, SJ; CHUN-JEN LIU; Chang, Chi-Yang; Lin, JW; PEI-JER CHEN; CHEN-HUA LIU; Hwang, JJ; Liu, CJ; PEI-MING YANG; DING-SHINN CHEN; Yang, PM; Lai, MY; JIA-HORNG KAO; Chen, PJ; Chen, JH; Kao, JH; Chen, DS.; Liu, CH; JUEY-JEN HWANG; Chang, Chi-Yang;Kao, JH;Lai, MY;Chen, DS.;Yang, PM;Hwang, JJ;Lin, JW;Hsu, SJ;Liu, CJ;Liu, CH;Chen, JH;Chen, PJ;JUEY-JEN HWANG;CHUN-JEN LIU;PEI-JER CHEN;CHEN-HUA LIU;PEI-MING YANG;DING-SHINN CHEN;JIA-HORNG KAO |
| 國家衛生研究院 |
2017-10 |
The c.1085A>G genetic variant of CSF1R gene regulates tumor immunity by altering the proliferation, polarization, and function of macrophages
|
Yeh, YM;Hsu, SJ;Lin, PC;Hsu, KF;Wu, PY;Su, WC;Chang, JY;Shen, MR |
| 國家衛生研究院 |
2017-01 |
A potent, selective, and orally bioavailable HCV NS5A inhibitor for treatment of Hepatitis C Virus: (S)-1-((R)-2-(Cyclopropanecarboxamido)-2-phenylacetyl)-N-(4-phenylthiazo l-2-yl)pyrrolidine-2-carboxamide
|
Kang, IJ;Hsu, SJ;Yang, HY;Yeh, TK;Lee, CC;Lee, YC;Tian, YW;Song, JS;Hsu, TA;Chao, YS;Yueh, A;Chern, JH |
Showing items 1-10 of 31 (4 Page(s) Totally)
1 2 3 4 > >>
View [10|25|50] records per page
|
